CD58 and neoplasm: CD58 mutation or downregulated expression is common in melanoma and hematological tumors, and downregulation of CD58 is associated with immune evasion in melanoma and that disruption of CD58 in tumor cells confers functional impairment of CAR T cells [46–48].